Monday, 21 Sep 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Finance
  • Clinical trial results
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
CompanyDrug

Innovent’s Tyvyt Combo Shows PFS Benefit in EGFR-Mutant NSCLC

February 10, 2025
CompanyDeals

Huadong Medicine Pays EUR 105M for 35% Stake in Heidelberg Pharma

February 10, 2025
CompanyDeals

CStone Pharmaceuticals Partners with Rigen Biotech on Thyroid Cancer RET Gene Testing

February 10, 2025
CompanyDeals

Biocytogen and FineImmune Partner on Innovative Cell Therapy Drug Development

February 10, 2025
CompanyDeals

CMS’s Rxilient Medical Licenses Insulin Products from Hefei Tianmai Biotech

February 10, 2025
CompanyDeals

Kelun Pharmaceutical Receives USD 35 Million from Merck Sharp & Dohme Corp.

February 10, 2025
CompanyDrug

Hainan Yuekang’s YK-029A Biosimilar Set for BTD in EGFR ex20ins NSCLC

February 10, 2025
CompanyDrug

Walvax Biotech Enrolls First Subject in Phase III HPV Vaccine Study

February 10, 2025
CompanyDrug

Sinocelltech’s Ripertamab Officially Launched in China for DLBCL Treatment

February 10, 2025
CompanyDrug

Innovent’s Tyvyt Shows PFS Benefit in EGFR-Mutant NSCLC at ESMO

February 10, 2025
CompanyDrug

Luye Pharma’s CD25 Monoclonal Antibody BA1106 Gains NMPA Approval for Clinical Trials

February 10, 2025
CompanyDeals

Fosun Pharma Inks Licensing Deal with Neovii for GvHD Therapy Grafalon

February 10, 2025
1 2 … 13 14 15 16 17 … 19 20
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up